Iglesias Juan Fernando
Clinical trials sponsored by Iglesias Juan Fernando, explained in plain language.
-
New stent combo could shorten blood thinner use for major heart artery blockage
Disease control Recruiting nowThis trial tests a new type of stent (Supraflex Cruz) combined with a shorter course of blood thinners (only 1-3 months of dual therapy, then just one drug) for people with a blockage in the left main coronary artery. The goal is to see if this approach reduces bleeding risks whi…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Heart attack patients may ditch aspirin sooner with new stent
Disease control Recruiting nowThis study tests a new drug-coated stent and a blood thinner strategy without aspirin for people who have had a severe heart attack. The goal is to see if this approach lowers the risk of serious bleeding while still preventing future heart attacks, strokes, or the need for anoth…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Wrist access showdown: could a new approach reduce artery blockage after heart surgery?
Knowledge-focused Recruiting nowThis trial tests whether using a wrist artery access point closer to the hand (distal radial) is safer than the usual wrist access for complex heart procedures like opening blocked arteries. About 708 adults with stable or unstable heart conditions will be randomly assigned to on…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC